High Content Screening (HCS) Market
Dublin, June 19, 2024 (GLOBE NEWSWIRE) — The “High Content Screening (HCS) – Global Strategic Business Report” report has ResearchAndMarkets.com Recruitment.
The global High Content Screening (HCS) market is estimated to reach USD 1.2 billion in 2023 and is projected to reach USD 2.2 billion by 2030, growing at a CAGR of 9.1% from 2023 to 2030. This comprehensive report provides a detailed analysis of market trends, drivers, and forecasts to help you make informed business decisions.
Report highlights:
-
Comprehensive market data: Independent analysis of annual revenue and market forecasts (in USD millions) from 2023 to 2030.
-
Detailed regional analysis: In-depth analysis of key markets including the United States, China, Japan, Canada, Europe, Asia Pacific, Latin America, Middle East and Africa.
-
Company Profiles: Features key companies such as BD Biosciences, BioTek Instruments Inc., and EMD Millipore.
-
Free Updates: Receive free report updates for one year to stay up to date with the latest market trends.
Key insights:
-
Market Growth: Understand the significant growth trajectory of the HCS equipment segment, which is expected to reach USD 1 billion by 2030 at a CAGR of 9.3%. The HCS consumables segment is also expected to grow at a CAGR of 8.2% over the next seven years.
-
Regional Analysis: Gain insights into the US market, estimated to reach $309.7 million in 2023, and the Chinese market, projected to grow at a staggering CAGR of 12.2% to reach $492.7 million by 2030. Discover growth trends in other key regions including Japan, Canada, Germany, and Asia Pacific.
Reasons to buy this report:
-
Detailed Market Analysis: Access an in-depth analysis of the global High Content Screening (HCS) market, covering all major geographic regions and market segments.
-
Competitive Insights: Get an overview of the competitive landscape including the market presence of key players across various regions.
-
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the global High Content Screening (HCS) market.
-
Actionable Insights: Leverage actionable insights that help you identify new revenue opportunities and make strategic business decisions.
Answers to your main questions:
-
How is the global High Content Screening (HCS) market expected to develop by 2030?
-
What are the key drivers and restraints impacting the market?
-
Which market segment will witness the highest growth during the forecast period?
-
How will the market shares of different regions and segments change by 2030?
-
Who are the key players in the market and what are their prospects?
Select your competitors (21 in total):
-
BD Biosciences
-
Biotech Instruments Co., Ltd.
-
EMD Millipore
-
Essen Bioscience
-
Evotec AG
-
GE Healthcare Life Sciences
-
Genedata AG
-
IntelliSight, Inc.
-
Molecular Devices, Inc.
-
PerkinElmer Co., Ltd.
-
Thermo Fisher Scientific Inc.
-
TTP LabTech Co., Ltd.
-
Yokogawa Electric Corporation
MarketGlass Platform
Our reports are powered by the MarketGlass platform, which brings together industry experts and influencers to deliver high-quality, accurate insights. This unique platform enables us to collect comprehensive data and market outlook, ensuring that we bring you the most reliable and in-depth analysis.
Major features
|
Report Attributes |
detail |
|
number of pages |
183 |
|
Forecast Period |
2023-2030 |
|
Estimated market value in 2023 (USD) |
$1.2 billion |
|
Market value forecast to 2030 (USD) |
$2.2 billion |
|
Compound Annual Growth Rate |
9.1% |
|
Target area |
global |
For more information on this report, please visit: https://www.researchandmarkets.com/r/lmjp8a
About ResearchAndMarkets.com
ResearchAndMarkets.com is a leading global source of international market research reports and market data providing the latest information on international markets, regional markets, key industries, top companies, new products and latest trends.
Attachments
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
